Literature DB >> 29114477

Erratum to current state of immunotherapy for non-small cell lung cancer.

Jyoti Malhotra1, Salma K Jabbour1, Joseph Aisner1.   

Abstract

[This corrects the article on p. 196 in vol. 6, PMID: 28529902.].

Entities:  

Year:  2017        PMID: 29114477      PMCID: PMC5653524          DOI: 10.21037/tlcr.2017.08.08

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN: 2218-6751


  1 in total

Review 1.  Current state of immunotherapy for non-small cell lung cancer.

Authors:  Jyoti Malhotra; Salma K Jabbour; Joseph Aisner
Journal:  Transl Lung Cancer Res       Date:  2017-04
  1 in total
  2 in total

1.  Effects of compound Kushen injection on pathology and angiogenesis of tumor tissues.

Authors:  Hongyan Wang; Haiyan Hu; Hua Rong; Xuwei Zhao
Journal:  Oncol Lett       Date:  2018-12-21       Impact factor: 2.967

2.  Prospective evaluation of EBUS-TBNA specimens for programmed death-ligand 1 expression in non-small cell lung cancer patients: a pilot study.

Authors:  Juliana Guarize; Elena Guerini Rocco; Filippo de Marinis; Giulia Sedda; Luca Bertolaccini; Stefano Maria Donghi; Monica Casiraghi; Clementina Di Tonno; Massimo Barberis; Lorenzo Spaggiari
Journal:  J Bras Pneumol       Date:  2021-07-12       Impact factor: 2.624

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.